Menno A Brink
Overview
Explore the profile of Menno A Brink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Umans D, Timmerhuis H, Anten M, Bhalla A, Bijlsma R, Boxhoorn L, et al.
Br J Surg
. 2023 Oct;
110(12):1877-1882.
PMID: 37811814
Background: Cholecystectomy in patients with idiopathic acute pancreatitis (IAP) is controversial. A randomized trial found cholecystectomy to reduce the recurrence rate of IAP but did not include preoperative endoscopic ultrasonography...
2.
Peters N, Constantinides A, Ubink I, van Kuik J, Bloemendal H, van Dodewaard J, et al.
Front Oncol
. 2022 Sep;
12:969855.
PMID: 36147916
Background: Mesenchymal Consensus Molecular Subtype 4 (CMS4) colon cancer is associated with poor prognosis and therapy resistance. In this proof-of-concept study, we assessed whether a rationally chosen drug could mitigate...
3.
Umans D, Timmerhuis H, Hallensleben N, Bouwense S, Anten M, Bhalla A, et al.
BMJ Open
. 2020 Aug;
10(8):e035504.
PMID: 32819938
Introduction: Idiopathic acute pancreatitis (IAP) remains a dilemma for physicians as it is uncertain whether patients with IAP may actually have an occult aetiology. It is unclear to what extent...
4.
Simsek M, Meijer B, Ramsoekh D, Bouma G, van der Wouden E, den Hartog B, et al.
Clin Gastroenterol Hepatol
. 2018 May;
17(3):568-570.
PMID: 29775790
Nodular regenerative hyperplasia (NRH) is a poorly understood liver condition, which is increasingly recognized in thiopurine-treated patients with inflammatory bowel disease (IBD). It is difficult to establish an optimal approach...
5.
Ponsioen C, de Groof E, Eshuis E, Gardenbroek T, Bossuyt P, Hart A, et al.
Lancet Gastroenterol Hepatol
. 2017 Aug;
2(11):785-792.
PMID: 28838644
Background: Treatment of patients with ileocaecal Crohn's disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also offer excellent short-term and...
6.
Walter D, van Boeckel P, Groenen M, Weusten B, Witteman B, Tan G, et al.
Eur J Gastroenterol Hepatol
. 2016 Oct;
29(2):231-237.
PMID: 27741030
Objective: For palliation of extrahepatic bile duct obstruction, self-expandable metal stents (SEMS) are superior to plastic stents in terms of stent patency and occurrence of stent dysfunction. We assessed health-related...
7.
Opstelten J, de Wijkerslooth L, Leenders M, Bac D, Brink M, Loffeld B, et al.
Dis Esophagus
. 2016 Feb;
30(2):1-7.
PMID: 26919349
Various treatments are available for the palliation of esophageal cancer, but the optimal therapeutic approach is unclear. This study aimed to assess the palliative treatment modalities used in patients with...
8.
Ali U, Issa Y, Hagenaars J, Bakker O, Goor H, Nieuwenhuijs V, et al.
Clin Gastroenterol Hepatol
. 2016 Jan;
14(5):738-46.
PMID: 26772149
Background & Aims: Patients with a first episode of acute pancreatitis can develop recurrent or chronic pancreatitis (CP). However, little is known about the incidence or risk factors for these...
9.
da Costa D, Bouwense S, Schepers N, Besselink M, van Santvoort H, van Brunschot S, et al.
Lancet
. 2015 Oct;
386(10000):1261-1268.
PMID: 26460661
Background: In patients with mild gallstone pancreatitis, cholecystectomy during the same hospital admission might reduce the risk of recurrent gallstone-related complications, compared with the more commonly used strategy of interval...
10.
Buijs J, Cahen D, van Heerde M, Rauws E, Maillette de Buy Wenniger L, Hansen B, et al.
Pancreas
. 2015 Sep;
44(7):1065-71.
PMID: 26355549
Objective: To evaluate the long-term outcome of autoimmune pancreatitis. Methods: Patients with at least 2 years of follow-up were included. Information was collected regarding disease characteristics, treatment outcome, diagnosed malignancies,...